ICU sedation, delirium & recovery

One-Year Mortality and Hospital Readmission in Survivors of COVID-19 Critical Illness—A Population-Based Cohort Study

Crit Care MedPublished Population-based retrospective observational cohort study

Main finding · 1-year mortalityResult — go to the resultHazard ratio 0.67 95% CI 0.58–0.78

Authors' conclusion

Risk of ED visit, hospital readmission, ICU readmission, and mortality within 1 year of discharge among survivors of COVID-19 critical illness was lower than survivors of critical illness from non-COVID-19 pneumonia.

Study context

Population
Adult (≥ 18 yr) survivors of ICU admission with COVID-19, 102 centers, Ontario, Canada
Participants
6,098 vs 2,568
Exposure
COVID-19 vs Non-COVID-19 pneumonia
  • COVID-19n = 6,098
  • Non-COVID-19 pneumonian = 2,568reference
Outcome
Mortality
Follow-up
1 year
Methodological detailsoverlap propensity score-weighted, cause-specific proportional hazard models
  • Overlap propensity score-weighted
  • Cause-specific proportional hazard models

Main finding

1-year mortality

Hazard ratio

0.67

95% CI 0.58–0.78

COVID-19 vs Non-COVID-19 pneumonia
HR 0.67 (95% CI 0.58–0.78)

As reported in the abstract

Died within 1 yr (COVID-19 critical illness survivors)
917 (15.0%)

Observational data: associations, not effects.

Further findings

OutcomeHR (95% CI)
ED visit · 1 year0.65 (0.60–0.71)
Hospital readmission · 1 year0.56 (0.51–0.62)
ICU readmission · 1 year0.44 (0.37–0.53)
Hospital readmission — Readmitted to hospital (COVID-19 critical illness survivors)
1610 (26.4%)
ICU readmission — Readmitted to ICU (COVID-19 critical illness survivors)
375 (6.1%)

Original publication

One-Year Mortality and Hospital Readmission in Survivors of COVID-19 Critical Illness—A Population-Based Cohort Study. Crit Care Med. Published 27 February 2025. doi:10.1097/ccm.0000000000006603

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.